Dramatic resolution of respiratory symptoms with imatinib mesylate in patients with chronic myeloid leukemia presenting with lower airway symptoms resembling asthma.
Ramanujam
Deivasikamani
D
McNicholl
Feargal
F
Furby
Darshayani
D
Richardson
Deborah
D
Cuthbert
Robert J G
RJ
McMullin
Mary F
MF
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001250:Asthma, Exercise-Induced / Q000175:diagnosis*; D001402:B-Lymphocytes / Q000378:metabolism; D001549:Benzamides; D003371:Cough / Q000188:drug therapy / Q000209:etiology; D003951:Diagnostic Errors; D004417:Dyspnea / Q000097:blood / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D015444:Exercise; D006801:Humans; D000068877:Imatinib Mesylate; D015466:Leukemia, Myeloid, Chronic-Phase / Q000097:blood / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D017997:Leukotriene C4 / Q000378:metabolism; D008297:Male; D010257:Paraneoplastic Syndromes / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D010879:Piperazines / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012074:Remission Induction
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D017997:Leukotriene C4; D000068877:Imatinib Mesylate